Bausch Health director receives $250K RSU grant

GOETTLER MICHAEL reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

GOETTLER MICHAEL reported acquisition or exercise transactions in this Form 4 filing.

Bausch Health Companies Inc. director Michael Goettler received an equity compensation grant in the form of 45,871 restricted share units (RSUs) with a stated grant date value of $250,000. These RSUs vest immediately before the company’s next Annual Meeting of Shareholders and will be settled in common shares, increasing his direct holdings to 76,020 shares.

Insider Trade Summary

Grant/Award: 45,871 shares

Grant/Award 1 txn

Insider GOETTLER MICHAEL

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	45,871	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 76,020 shares (Direct)

Footnotes (1)

1. F1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Key Figures

RSUs granted: 45,871 units Grant date value: $250,000 Price per share: $0.0000/share +1 more

4 metrics

RSUs granted 45,871 units Equity award to non-employee director Michael Goettler

Grant date value $250,000 Value of RSU award to non-employee directors

Price per share $0.0000/share Accounting grant price for RSU acquisition on Form 4

Shares after transaction 76,020 shares Total Bausch Health common shares held directly after award

Key Terms

restricted share units ("RSUs"), grant date value, Annual Meeting of Shareholders, vest, +1 more

5 terms

restricted share units ("RSUs") financial

"Represents the award of restricted share units ("RSUs") granted to non-employee directors"

grant date value financial

"The RSUs have a grant date value of $250,000, vest on the date"

Annual Meeting of Shareholders financial

"granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

vest financial

"The RSUs have a grant date value of $250,000, vest on the date immediately preceding"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

settled in common shares financial

"and are settled in common shares, no par value, of the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bausch Health (BHC) director Michael Goettler report on this Form 4?

Michael Goettler reported receiving 45,871 restricted share units (RSUs) of Bausch Health as equity compensation. The RSUs have a grant date value of $250,000 and were awarded as part of the company’s standard program for non-employee directors following their election at the Annual Meeting.

How many Bausch Health (BHC) shares does Michael Goettler hold after this RSU grant?

After the reported RSU award, Michael Goettler’s direct holdings total 76,020 Bausch Health common shares. The 45,871 RSUs will be settled in common shares when they vest, aligning his compensation with long-term shareholder interests through additional equity exposure.

What are the key terms of Michael Goettler’s RSU grant at Bausch Health (BHC)?

The RSU grant to Michael Goettler has a grant date value of $250,000 and was issued on the third business day after his election at the Annual Meeting. These restricted share units vest immediately before the next Annual Meeting and are then settled in Bausch Health common shares.

Is Michael Goettler’s Bausch Health (BHC) Form 4 transaction an open-market purchase?

No, the Form 4 transaction reflects a grant of restricted share units as compensation, not an open-market purchase. The shares were acquired at a price of $0.0000 per share, consistent with equity awards granted to non-employee directors under the company’s compensation program.

When do Michael Goettler’s Bausch Health (BHC) RSUs vest and settle into shares?

The RSUs granted to Michael Goettler vest on the date immediately preceding Bausch Health’s next Annual Meeting of Shareholders. Once vested, they are settled in common shares of the company, converting the restricted share units into freely owned equity for the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 06:14 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GOETTLER MICHAEL

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	05/22/2026		A		45,871(1)	A	$0	76,020	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

	/s/ Brianna M. Dorsi, attorney-in-fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)